Well done. More spin than a top. More flowery adjectives than a...

First 8290 Last

Share
Profile

Follow
Cacoethes

126 Posts.

1

21/02/22

15:03

Post #: 59709160
Share

Originally posted by nevchev: ↑

Are high lithium prices here to stay? Industry insiders say yes

One industry veteran unequivocally believes strong lithium prices will persist…
The sheer incline in lithium prices over the past year has left many investors with their jaws unhinged and on the floor. Shockingly, many industry experts suspect these remarkable prices will continue into the future.
Fattening the pockets of anyone in the lithium game, thecommodity price has increased about 525% in the last 12 months. This has led to ASX lithium shares such as Pilbara Minerals Ltd(ASX: PLS) and Liontown Resources Limited(ASX: LTR) exploding 181% and 291% in value, respectively.
However, the all-important question is: can it stay this way? Well, based on the perspectives of certain mining veterans and analysts, the answer is a resounding — yes.
Fundamentals are on the right side of lithium prices

When searching for credible insights, nearly 32 years of industry experience doesn’t go astray. That’s how well-accustomed former Fortescue Metals Group Limited(ASX: FMG) exec and mining veteran, Greg Lilleyman, is to the commodity game.
Having served as chief operating officer at Fortescue, Lilleyman has shared in the success of booming industries — such as iron ore — in his time. Although, after leaving the $60 billion iron ore behemoth, Lilleyman has been salivating over a commodity of a different kind.
Joining the board of Global Lithium Resources Ltd(ASX: GL1) as a non-executive director, Lilleyman is banking on lithium prices to benefit from decarbonisation tailwinds. Global Lithium is another ASX-listed lithium name that has enjoyed astonishing returns of late. For context, the company’s shares are up 435% in the past year.
Lilleyman expects the commodity commonly used in electric vehicle (EV) batteries will be a winner moving forward, stating:
Prices go up, prices go down. But I genuinely believe structurally the prices will remain solid in the spodumene and lithium space because the fundamentals say it should. There’s nothing speculative about it.
Importantly, the veteran draws attention to a shortage of mines producing high-quality lithium. In addition, Lilleyman expects supply to be harder to source and more expensive due to environmental reasons and increased taxes. These factors combined could push lithium prices even further to the upside.

Analysts on the same page

Lilleyman is not alone in his assessment of the burgeoning lithium industry. Recently analysts from Citigroup and UBS have both shared a positive sentiment for future lithium prices.
Firstly, Citigroup outlined its expectations for an extreme lithium deficit in 2022. Additionally, the lack of lithium projects in the pipeline has led the analysts to raise their long-term price forecast by 36%.
Referencing an expected 10.7 million EV’s to be sold in 2022, Citigroup analysts stated:
EV penetration is on an ‘S-curve’ and high lithium prices are here to stay.
Meanwhile, the team over at UBS is supportive of these forecasts. Adding that the investment bank believes climate-friendly government policy will squash internal combustion engine vehicle sales by 2040.

Expand

Well done. More spin than a top. More flowery adjectives than a school prom. More embellishment than the Sistine chapel. Very mpressive use of language to mask the banality of the message. Great skills in an election year.

CXO Price at posting: 80.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 31,028 more messages in this thread...

First 8290 Last

Add CXO (ASX) to my watchlist

(20min delay)
Last 12.5¢		Change 0.010(8.70%)		Mkt cap ! $267.8M

Open	High	Low	Value	Volume
12.0¢	13.0¢	11.5¢	$2.025M	16.45M

Buyers (Bids)

No.	Vol.	Price($)
19	1779853	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.0¢	7625975	76

View Market Depth

No.	Vol.	Price($)
18	1755853	0.125
35	2623164	0.120
50	6865092	0.115
90	5450520	0.110
61	4772084	0.105

Price($)	Vol.	No.
0.130	7625975	76
0.135	2995321	45
0.140	1665232	32
0.145	1400987	26
0.150	1132501	28

Last trade - 16.10pm 07/10/2024 (20 minute delay)

CXO (ASX) Chart

Well done. More spin than a top. More flowery adjectives than a...

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Well done. More spin than a top. More flowery adjectives than a...

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News